Home / Request for Information (RFI) - Specialty Pharmacy List … / Document

Bid document

Updated

A Word document (15 KB) attached to Request for Information (RFI) - Specialty Pharmacy List - Pharmaceutical Prime Vendor (PPV) 2028, from the Department of Veterans Affairs. Due Nov 16, 2026, 11:00 AM (UTC-6).

File name: 36E79727Q0001 0001_1.docx

Download the full documentSee the bid

The full file is for paid members, or buy this bid alone.

Preview



SUBJECT*

Request for Information (RFI) - Specialty Pharmacy List - Pharmaceutical Prime Vendor (PPV) 2028

GENERAL INFORMATION

CONTRACTING OFFICE’S ZIP CODE*

60141

SOLICITATION NUMBER*

36E79727Q0001

BASE NOTICE TYPE

RESPONSE DATE/TIME/ZONE

11-16-2026 11am CENTRAL TIME, CHICAGO, USA

ARCHIVE

60 DAYS AFTER THE RESPONSE DATE

RECOVERY ACT FUNDS

N

SET-ASIDE

PRODUCT SERVICE CODE*

6505

NAICS CODE*

325412

CONTRACTING OFFICE ADDRESS

Department of Veterans Affairs - OALC
Enterprise Procurement Office (EPO)
Acquisition Service 7 (AS7)
Bldg 37, PO Box 76
Hines, IL 60141

POINT OF CONTACT*

Chief, Pharmaceutical Division
Karen Ade
[email protected]
708-786-5231

PLACE OF PERFORMANCE

ADDRESS

POSTAL CODE

COUNTRY

ADDITIONAL INFORMATION

AGENCY’S URL

URL DESCRIPTION

AGENCY CONTACT’S EMAIL ADDRESS

EMAIL DESCRIPTION

DESCRIPTION

AMENDMENT 0001 – Request for Information (RFI) 36E79727Q0001 Specialty Pharmacy - Pharmaceutical Prime Vendor (PPV) 2028 Purpose of Amendment: This amendment provides a list of Specialty Products on FSS Not Distributed Through PPV. Attachment: Attachment 1 – Specialty Products on FSS Not Distributed Through PPV The attached list identifies specialty pharmaceutical products currently on the Federal Supply Schedule (FSS) that are not presently distributed through the Pharmaceutical Prime Vendor (PPV) program. The list is provided for reference purposes only and may include products that are subject to specialty, limited, closed, or other restricted distribution models. Inclusion on this list should not be interpreted as confirmation that a product is a Limited Distribution Drug (LDD) or Closed Distribution Product (CDP). Distribution arrangements, manufacturer requirements, and product availability may change over time; therefore, this list is not intended to be exhaustive and should be considered a point-in-time reference only. Response Date: Unchanged. Responses are due no later than 11:00 AM Central Time, November 16, 2026, via email to [email protected]. All other information in the RFI remains unchanged.
See attached document: Attachment 1 _ Specialty Products on FSS Not Distributed Through PPV.

The beginning of the document. Download the full file to read on.

Other documents in this bid